TYLE PRAVEEN 4
4 · Skye Bioscience, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
TYLE PRAVEEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-05+250,000→ 250,000 totalExercise: $0.02Exp: 2033-01-05→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 (the "Grant Date") and the options will vest in equal monthly installments over the one year period from the Grant Date.